Video 15Video1Video2Video3Video4Video5Video6Video7Video8Video9Video10Video11Video12Video13(Mexico)Video14Video15(Espanol)Video16Disclaimer:
Individual results vary. Anti-TNF treatment for the indications
below is off-label. Please see the Legal Disclaimer. Maintenance dosing, usually
weekly, but sometimes as little as monthly, is necessary for optimal
effect. The methods of anti-TNF treatment utilized for these patients
are patented inventions of the INR[1].Video 15: Family flies to the INR from Mexico
for PSE treatment of dementia - results at 1 month (in Spanish
(Espanol)* video length
1:26 minutes
This video, filmed at
the INR® in Los Angeles on July 13, 2009, documents the improvement
sustained through one month following treatment with perispinal
etanercept (PSE) in a patient who had flown to the INR® in
Los Angeles from Mexico one month before (on June 15 2009). This
video in nearly entirely in Spanish (Espanol) . Please see Perispinal
etanercept for neuroinflammatory disorders. Edward
Tobinick MD. Drug Discovery Today 2009 Feb; 14(3-4):168-77.The
videos above are interviews discussing and documenting the clinical
response to initiation of anti-TNF treatment (perispinal etanercept)
at the INR. For the published results please see
Tobinick E, Gross H, Weinberger A, Cohen H., TNF-alpha Modulation
for Treatment of Alzheimer's Disease: A 6-Month Pilot Study
MedGenMed 2006; 8(2) :25; Tobinick E., Perispinal etanercept
for treatment of Alzheimer's disease, Current Alzheimer
Research 2007 Dec; 4(5):550-2; Tobinick E, Gross H., Rapid
improvement in verbal fluency and aphasia following perispinal
etanercept in Alzheimer's disease, BMC Neurology 2008;
8:27; and Tobinick E., Perispinal etanercept for neuroinflammatory
disorders, Drug Discovery Today 2009 Feb; 14(3-4):168-77.Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095
Video2